肠炎宁片通过抑制GPX4介导的铁死亡缓解克罗恩病
该研究基于TNBS诱导的克罗恩病大鼠模型及体外细胞实验,探讨肠炎宁片(CYN)对克罗恩病的干预作用及机制。结果表明CYN可改善铁死亡相关指标(GSH、MDA、GPX4、SLC7A11),并通过抑制GPX4介导的铁死亡缓解克罗恩病,芦丁、迷迭香酸和山奈酚-3-O-槐糖苷为其关键活性成分。
要点
- CYN可改善TNBS诱导CD大鼠结肠铁死亡相关指标。
- CYN通过靶向GPX4抑制铁死亡缓解克罗恩病。
- 芦丁、迷迭香酸和山奈酚-3-O-槐糖苷为抑制铁死亡的关键成分。
核心结论
- CYN通过抑制GPX4介导的铁死亡缓解克罗恩病,提示其治疗CD的临床潜力。
研究设计与样本
- 基于TNBS诱导的克罗恩病大鼠模型进行体内实验,并结合体外细胞实验验证。
- 使用siRNA敲低GPX4进行反向验证,并采用UPLC-MS鉴定活性成分。
主要发现
- CYN显著改善TNBS诱导CD大鼠结肠中铁死亡相关指标GSH、MDA、GPX4和SLC7A11。
- 在三种铁死亡诱导剂(RSL3、FINO2、erastin)中,CYN对RSL3(靶向GPX4的铁死亡诱导剂)诱导的凋亡最为有效。
- CYN对RSL3诱导的铁死亡具有抵抗作用,并在体内减轻RSL3灌肠诱导的CD样肠道损伤。
- HCoEpiC细胞中siRNA敲低GPX4进一步验证GPX4是CYN抑制铁死亡的主要靶点。
- UPLC-MS和体外实验鉴定芦丁、迷迭香酸和山奈酚-3-O-槐糖苷为CYN抑制铁死亡的关键活性成分。
关键数值与推荐
- CYN显著改善TNBS诱导CD大鼠结肠中GSH、MDA、GPX4和SLC7A11等铁死亡相关指标。
- 在RSL3、FINO2和erastin三种铁死亡诱导剂中,CYN对RSL3(靶向GPX4)诱导的凋亡最为有效。
临床怎么用
- CYN可能作为抑制GPX4介导铁死亡的候选药物用于克罗恩病治疗。
- 芦丁、迷迭香酸和山奈酚-3-O-槐糖苷可作为CYN质量控制或活性成分研究的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Changyanning tablets (CYN) are a marketed traditional Chinese medicine composed of Diijincao (Euphorbia humifusa Willd.), Jinmaoercao (Hedyotis chrysotricha (Palib.) Merr.), Zhangshugen (root of Cinnamomum camphora (L.) J.Presl), Xiangru (Elsholtzia ciliate (Thunb.) Hyl.), and Fengxiangshuye (leaf of Liquidambar formosana Hance). They possess the functions of clearing heat, removing dampness, and regulating qi. CYN is used for the treatment of diarrhea and dysentery caused by damp heat in the large intestine, with symptoms such as diarrhea, or stools with pus and blood, tenesmus, abdominal pain and distension, acute and chronic gastroenteritis, diarrhea, bacterial diarrhea, and indigestion in children. AIM OF THE STUDY: This study aims to explore the intervention effects of CYN on Crohn's disease (CD) and its potential mechanisms. MATERIALS AND METHODS: The therapeutic effect and potential mechanism of CYN on CD were investigated based on the 2,4,6-Trinitrobenzenesulfonic acid solution (TNBS)-induced rat model. In vivo and in vitro experiments confirmed that CYN can alleviate CD by inhibiting GPX4-mediated ferroptosis. siRNA was used to knock down GPX4 for reverse validation. Finally, active components of CYN inhibiting ferroptosis were identified using UPLC-MS and the RSL3-induced HCoEpiC ferroptosis cell model. RESULTS: CYN significantly improved ferroptosis-related indicators (GSH, MDA, GPX4, and SLC7A11) in the colons of TNBS-induced CD rats. Screening with three ferroptosis inducers (RSL3, FINO2, and erastin) revealed that CYN was most effective against RSL3 (a ferroptosis inducer targeting GPX4)-induced apoptosis. Subsequently, the resistance effect of CYN on RSL3-induced ferroptosis was confirmed in vitro. Further in vivo experiments showed that CYN alleviated local CD-like intestinal injury induced by RSL3 enema. siRNA knockdown of GPX4 in HCoEpiC cells further validated GPX4 as major target of CYN in inhibiting ferroptosis. Finally, UPLC-MS and in vitro experiments identified rutin, rosmarinic acid, and kaempferol-3-O-sophoroside as key active components of CYN for inhibiting ferroptosis. CONCLUSIONS: CYN alleviates CD by inhibiting GPX4-mediated ferroptosis, highlighting its clinical potential for treating CD and enhancing the understanding of the pathogenic and therapeutic mechanisms associated with CD.
引用
- Huang Y, Ru Q, Ruan H, et al. Changyanning tablet alleviates Crohn's disease by inhibiting GPX4-mediated ferroptosis. J Ethnopharmacol. 2025. PMID: 39870334. doi:10.1016/j.jep.2025.119415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。